Nuvation Bio Inc (NUVB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 258,604 | 125,391 | 164,086 | 98,897 | 247,970 |
| Marketable Securities | 402,352 | 408,338 | 365,125 | 450,148 | 359,752 |
| Receivables | 31,714 | 25,984 | 19,361 | 13,850 | 6,677 |
| Inventories | 19,901 | 15,844 | 11,411 | 5,710 | 552 |
| TOTAL | $726,432 | $591,529 | $571,519 | $577,530 | $623,208 |
| Non-Current Assets | |||||
| PPE Net | 715 | 535 | 564 | 560 | 615 |
| Intangibles | 10,292 | 10,755 | 11,214 | 11,680 | 12,145 |
| Other Non-Current Assets | 7,064 | 7,422 | 11,525 | 11,791 | 11,257 |
| TOTAL | $18,071 | $18,712 | $23,303 | $24,031 | $24,017 |
| Total Assets | $744,503 | $610,241 | $594,822 | $601,561 | $647,225 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 5,893 | 5,790 | 5,724 | 5,618 | 5,583 |
| Accounts payable and accrued liabilities | 12,089 | 22,435 | 9,479 | 15,360 | 22,419 |
| Accrued Expenses | 45,204 | 32,864 | 45,183 | 32,579 | 23,998 |
| Other current liabilities | 21,854 | 16,595 | 19,965 | 12,703 | 12,548 |
| TOTAL | $86,755 | $79,522 | $82,231 | $68,131 | $66,356 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 47,327 | 47,208 | 47,089 | 46,974 |
| Other Non-Current Liabilities | 403,884 | 163,828 | 159,667 | 160,459 | 160,988 |
| TOTAL | $403,884 | $211,155 | $206,875 | $207,548 | $207,962 |
| Total Liabilities | $490,639 | $290,677 | $289,106 | $275,679 | $274,318 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 351,123 | 348,202 | 347,597 | 342,833 | 342,273 |
| Common Shares | 1,429,288 | 1,431,214 | 1,421,273 | 1,404,799 | 1,396,220 |
| Retained earnings | -1,172,813 | -1,109,973 | -1,115,370 | -1,078,778 | -1,022,986 |
| Other shareholders' equity | -2,611 | -1,677 | -187 | -139 | -327 |
| TOTAL | $253,864 | $319,564 | $305,716 | $325,882 | $372,907 |
| Total Liabilities And Equity | $744,503 | $610,241 | $594,822 | $601,561 | $647,225 |